Highmark Marketing Inc.
CNSX : HMK

Highmark Marketing Inc.

June 18, 2014 09:28 ET

Highmark Appoints James "Bo" Keyes of Bud Basics to Its Advisory Committee

VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 18, 2014) -

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.

Highmark Marketing Inc. (CSE:HMK) ("Highmark" or the "Company") is pleased to announce that it has appointed Mr. James "Bo" Keyes to the Advisory Committee.

James "Bo" Keyes has a great depth of knowledge and experience in the marijuana industry. He is the Founder and Creator of Bud Basics (www.budbasics.com), which is currently the only Standards & Certification Company specifically designed for the marijuana industry. Bud Basics is passionate about cannabis and has vision to dramatically increase the safety, best practices, quality and consistency within all "consumer facing" elements of the supply chain. Bud Basics 4200 Certification ensures a quality product is produced throughout the cannabis supply chain from "seed to sale".

Prior to Bud Basics Mr. Keyes was the Founder and Quality Director at Vape Holdings where he created an industry leading Vaporizer Company from scratch, and as Director of Quality (QA) his responsibilities included managing the engineering team, supplier vetting, product selection, product testing, creation of Standard Operating Procedures (SOP), and establishing a quality management system.

Earlier in his career Mr. Keyes worked with an internationally accredited registrar for certification products including standards such as: ISO, SQF, FAA, as well as products in Ethical Sourcing and Sustainability Standards. Mr. Keyes has been an elected member of the U.S. TAG Committee to ISO/TC 207 on Environmental Management & ASC Z1 Subcommittee on Environmental Management Standards, gaining first-hand experience on the process of creating internationally recognized standards.

Mr. Keyes has agreed to participate in strategic meetings regarding Highmark's focus, and direction and in particular Highmark with insights regarding the US market. Mr. Keyes has also agreed to provide consulting services to Highmark on a project basis.

As consideration for services provided, the company will grant James "Bo" Keyes, in accordance with the policies of the Canadian Securities Exchange and the company's stock option plan, an incentive stock option to purchase 50,000 common shares in the capital of the company.

Highmark looks forward to working with James "Bo" Keyes and learning from his expertise to further Highmark's business in the medical marijuana sector.

About Highmark

Highmark is a nutraceutical company, based in British Columbia, focused on bringing the health benefits of natural and herbal remedies to the market. Highmark intends to license, distribute, market and distribute products in the nutraceutical industry.

Further information about Highmark is available under its profile on the SEDAR website www.sedar.com and on the CSE website http://thecse.ca/CNSX/Securities/Life-Sciences/Highmark-Marketing-Inc.aspx.

CSE has not reviewed, nor approved or disapproved the content of this press release.

Forward-Looking Information:

This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of Highmark. Forward-looking information is based on certain key expectations and assumptions made by the management of Highmark, including future plans for acquisitions. Although Highmark believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because Highmark can give no assurance that they will prove to be correct. Forward-looking statements contained in this press release are made as of the date of this press release. Highmark disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been and will not be registered under the United States Securities Act of 1933, as amended, or any applicable securities laws or any state of the United States and may not be offered or sold in the United States or to the account or benefit of a person in the United States absent an exemption from the registration requirements.

Contact Information